Related Articles
A drug targeting 5‑lipoxygenase enhances the activity of a JAK2 inhibitor in CD34<sup>+</sup> bone marrow cells from patients with JAK2V617F‑positive polycythemia vera <em>in vitro</em>
Molecular landscape of the <em>JAK2</em> gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil
Clinical significance of circulating microparticles in Ph- myeloproliferative neoplasms
Impact of <em>CYLD</em> on chromatin structure and histone methylation in malignant melanoma
pSTAT5 and ERK exhibit different expression in myeloproliferative neoplasms